EasiVits Acceptability & Tolerance Study
NCT07619170 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30
Last updated 2026-06-01
Summary
In order to achieve metabolic stability, dietary treatment of inborn errors of metabolism (IEM) may require restriction of protein (e.g. phenylketonuria, tyrosinaemia, homocystinuria, organic acidaemias, maple syrup urine disease (MSUD), urea cycle disorders), fat (e.g. fatty acid oxidation disorders) or carbohydrate (e.g. glycogen storage disease). Manipulation of dietary intake potentially reduces micronutrient status, and provision of a comprehensive vitamin and mineral supplement may become an essential adjunct to dietary treatment.
Paediatric Seravit and Frutivits are vitamin and mineral supplements that are currently available on prescription. Paediatric Seravit is designed for children between 1-3 years of age but has high amounts of added carbohydrate, restricting its use for patients with IEM with restricted carbohydrate intake. Fruitivits is designed for children over the age of 3 years and is orange flavoured, restricting patient's choice, potentially leading to poor adherence and taste fatigue.
Previous studies show that despite improvements in some nutritional markers using the currently available vitamin and mineral supplements, overall use of the vitamin and mineral supplements was less than prescribed and alternatives are needed to guarantee delivery of micronutrients in children at risk of deficiencies as a result of an essential manipulation of diet in inborn disorders of metabolism. Whilst condition specific formula for IEM often contains added micronutrients, there are global concerns about over- and under-supplementation and the impact on palatability. Consequently, some health professionals advocate the availability of unfortified products to enable individualised tailoring of micronutrient intake using a separate vitamin and mineral supplement. Furthermore, with the advent of pharmacological treatments for some IEM, there is evidence that cessation of specialist formula without significant changes to dietary food intake, commonly leads to deficiencies in several micronutrients.
EasiVits are new vitamin and mineral supplements which contain minimal carbohydrate and are unflavoured. This allows them to be used in carbohydrate restricted IEMs, and patients can also add their preferred flavours via permitted fruit cordials or drinks in order to potentially improve adherence and prevent taste fatigue.
Conditions
- Inborn Errors of Metabolism
Interventions
- DIETARY_SUPPLEMENT
-
UNO EasiVits
7-day administration of UNO EasiVits
- DIETARY_SUPPLEMENT
-
DUO EasiVits
7-day administration of DUO EasiVits
Sponsors & Collaborators
-
Birmingham Children's Hospital
collaborator OTHER -
NeoteriQ Ltd.
lead INDUSTRY
Principal Investigators
-
Anita MacDonald, PhD · Birmingham Children's Hospital
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-03-07
- Primary Completion
- 2026-09-23
- Completion
- 2026-09-23
Countries
- United Kingdom
Study Locations
More Related Trials
-
GMP Powdered Substitutes in PKU and TYR
NCT06941532 ·Status: RECRUITING ·Phase: NA
-
Formula for Children With Cow's Milk Allergy
NCT02317952 ·Status: COMPLETED ·Phase: NA
-
Tolerance of Healthy Term Infants Fed Infant Formulas
NCT00705562 ·Status: COMPLETED ·Phase: PHASE2
-
Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate
NCT01755481 ·Status: COMPLETED ·Phase: NA
-
Acceptability and Tolerance of a Ready-to-use Protein Substitute in Tablet Form for the Dietary Management of Phenylketonuria
NCT04375592 ·Status: COMPLETED
-
Healthy Term Infants Fed Milk-Based Infant Formula
NCT04529759 ·Status: COMPLETED ·Phase: NA
-
GMP Drink for PKU Study
NCT02915510 ·Status: COMPLETED ·Phase: NA
-
Evaluation of PKU Explore
NCT03168399 ·Status: COMPLETED ·Phase: NA
-
Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
NCT03667118 ·Status: COMPLETED ·Phase: NA
-
Phase 2 Study of Glycomacropeptide Versus Amino Acid Diet for Management of Phenylketonuria
NCT01428258 ·Status: COMPLETED ·Phase: NA
-
Lactose, Sucrose & Corn Syrup Tolerance
NCT01789307 ·Status: COMPLETED ·Phase: NA
-
A Prospective Study of the Four Food Elimination Diet for Treatment of Eosinophilic Esophagitis
NCT05176262 ·Status: ACTIVE_NOT_RECRUITING
-
Detection of Metabolite Biomarkers for the Early Diagnosis and Prognosis of Cow's Milk Allergy in Children
NCT04249973 ·Status: ACTIVE_NOT_RECRUITING
-
PKU EASY Microtabs Plus - Acceptability and Tolerance
NCT06694662 ·Status: COMPLETED ·Phase: NA
-
Soy Formula Feedings in Healthy, Term Infants
NCT02456831 ·Status: COMPLETED ·Phase: NA
-
Protein Requirements in Adults With Phenylketonuria (PKU)
NCT03939052 ·Status: COMPLETED ·Phase: NA
-
PKU Microtablets Case Studies
NCT07671859 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Nutritional Evaluation of Infants Receiving Amino Acid-Based Formula
NCT07174999 ·Status: NOT_YET_RECRUITING
-
Evaluation of the Efficacy of a New Formula in Infants With Cow's Milk Protein Allergy
NCT01998074 ·Status: COMPLETED ·Phase: NA
-
Prevention of Cow's Milk Allergy in Children
NCT00792090 ·Status: COMPLETED ·Phase: NA
-
Compliance, Tolerance and Acceptability of a Tablet Protein Substitute for the Dietary Management of Phenylketonuria
NCT03333720 ·Status: WITHDRAWN ·Phase: NA
-
Amino Acid Feed Children's Study
NCT02569840 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins
NCT03557671 ·Status: COMPLETED ·Phase: NA
-
Infant Formula in Infants and Children With Cow's Milk Allergy
NCT06456541 ·Status: RECRUITING ·Phase: NA
-
Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy
NCT07449507 ·Status: NOT_YET_RECRUITING ·Phase: NA